
Cancer research at Saint John’s Cancer Institute continues to promote greater understanding in oncology.
In its third year, our research report showcases groundbreaking science at the Providence Saint John’s Cancer Institute (SJCI). Our interdisciplinary research team includes scientists, medical oncologists, surgeons, pathologists, chemists, technologists, geneticists, and their clinical teams. We cover a broad spectrum of research areas: translational sciences, melanoma and cutaneous skin cancer, breast cancer, brain cancer and metastasis, kidney, pancreatic, prostate, lung, thyroid, ovarian cancer, colon cancer, bladder cancer, solid tumors, neurologic diseases, and screening efficiencies.
Why is Cancer Research Important?
Cancer research is central to Saint John’s Cancer Institute’s mission to understand and cure cancer. It drives new treatments and methodologies. SJCI aims to translate scientific discoveries into effective treatments through innovative clinical and laboratory research. For instance, breakthroughs in microRNA and liquid biopsies have positioned the institute among larger institutions, uncovering patterns that aid in cancer detection. Translational research bridges laboratory findings and clinical data, ensuring new therapies are safely and efficiently introduced into clinical practice, benefiting the most unique cancer patients.
This release marks three consecutive years of the research report, reflecting over 30 years of collaborative research with global organizations and our resolve to cure cancer.
– Dr. Dave SB Hoon, Director of SJCI Translational Research
The Saint John’s Cancer Institute emphasizes a multidisciplinary team approach to oncologic outcomes. Our collective environment brings together experts across disciplines to develop personalized treatment plans. For example, research involves collaboration with the Pacific Neuroscience Institute (PNI) to advance shared knowledge and create patient-specific treatments under the Providence care umbrella. In urology, we foster training in advanced robotic procedures and clinical trials, while breast cancer research combines oncoplastic surgical approaches with chemotherapy, targeted therapy, radiation, and immunotherapy to maximize patient benefit.
Thank you to our researchers, clinicians, fellows-in-training, and administrators. Through you, we are honored to be part of the impact you are making.
The more research we can do, the more our patients can do with their lives.
– Lynda Baxter, MBA, MPH, Executive Director, Providence Saint John’s Cancer Institute and
Roy and Patricia Disney Family Cancer Center (DFCC) at Providence Saint Joseph Medical Center.
SJCI Research Reports
Cutting-edge research is possible through grants and your donations.
If you would like to support cancer research, please click here.